IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Apr 2004 (Vol: 2004, Issue: 46)

Next Issue >>

Section: Company Profile
Eisai Co. Ltd Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Mayne to Market Paxene® in the EU Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Neurocrine Acquires Wyeth’s Financial Interest in Indiplon Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Serono and InDex in Ulcerative Colitis Deal Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Yamanouchi and Fujisawa Strive for Global Mega-Player Status with Merger Agreement Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Fisher Scientific to Buy Oxoid and Dharmacon for US$410 M Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Chiron and Xoma to Develop Anticancer Antibodies Published: 4 Apr-2004
By: Business Review Editor
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in